In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

President Address

Message from Stephan Windecker, EAPCI President 2014-2016

2014-2016 Objectives

EAPCI with 5900 members has become the 2nd largest Association of the European Society of Cardiology since its foundation in 2006 and has evolved into a dynamic structure under the leadership of highly dedicated individuals.

In the recently completed election, a new Board has been constituted by our members and it will be my privilege to lead the Association with the support of Michael Haude as President-Elect, Jean Fajadet as Past-President, Javier Escaned as Treasurer, Andreas Baumbach as Secretary, Patrick Serruys as Editor-in-Chief of EuroIntervention, and Petr Kala and Giulio Guagliumi as EuroPCR representatives. During the upcoming term 2014-2016 I will focus with the support of the Board on the following objectives:

Strengthen the scientific visibility of EAPCI

Interventional cardiovascular medicine is one the most vibrant and innovative disciplines within cardiology and has contributed immensely to improve patient outcome. The Association will build on previous efforts to further excel scientific knowledge and standards in several ways

  • Facilitate scientific consensus and position documents on relevant topics of interventional cardiovascular medicine
  • Assist to obtain European research funding support
  • Provide a networking platform for clinical research partnership
Make valvular heart disease interventions a key priority of the Association

The advent of transcatheter valve interventions is one of the most important recent advances in our field and cardiology as a whole. The Association will continue to advance this subspecialty in numerous ways

  • Participate in educational platforms such as PCR London Valves
  • Cooperate with other Associations such as EHRA, EACVI, HFA and the Working Group on Valvular Heart Disease to provide the highest standard of care to affected patients
  • Facilitate adoption of this new technology across Europe
Raise educational standards in interventional cardiovascular medicine

The prolific development in several domains including coronary interventions, transcatheter heart valve interventions, structural heart disease interventions, neurohumoral denervation and interventional pharmacology pose an increasing responsibility to provide a common ground of knowledge and expertise. The Association will further raise educational standards by:

  • Continued development of the ESC eLearning platform
  • Establishment of a regular European interventional cardiovascular fellow’s course
  • Provision of training grants for young interventional cardiology fellows
  • Involvement of nurses and technicians in the training process
Address gender differences in access, care and outcome

Inequalities in access to care particularly among female patients with acute coronary syndromes have been recognized. Moreover, minimal invasive treatments such as transcatheter heart valve interventions are particularly beneficial among female elderly patients. The Association will help to address these  and other issues via the dedicated EAPCI Women Committee.

Focus on the young interventional cardiovascular community

Investment in the upcoming and future interventional cardiovascular community will be a top priority to attract the most talented individuals into our subspecialty. The Association has implemented the Young Committee which will continue to develop specific initiatives such as CathGO adapted to the needs of young interventional cardiologists in training.